Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects
Yukimura Higashiura, Masato Furuhashi, Marenao Tanaka, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Mitigating Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Role of Bioactive Phytoconstituents in Indian Culinary Spices
Pervej Alom Barbhuiya, Ameena Ahmed, Partha Dutta, et al.
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Closed Access | Times Cited: 2
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease
Marenao Tanaka, Kazuma Mori, Satoko Takahashi, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 3, pp. 700-711
Closed Access | Times Cited: 38
Fatty liver index (FLI): more than a marker of hepatic steatosis
Anastasiya M. Kaneva, Evgeny R. Bojko
Journal of Physiology and Biochemistry (2023) Vol. 80, Iss. 1, pp. 11-26
Closed Access | Times Cited: 19
Coexistence of Metabolic Dysfunction‐Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease
Daisuke Miyamori, Marenao Tanaka, Tatsuya Sato, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 14
Open Access | Times Cited: 17
Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis
Kazuma Mori, Yukinori Akiyama, Marenao Tanaka, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 7, pp. 1382-1393
Open Access | Times Cited: 8
Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population
Satoko Takahashi, Marenao Tanaka, Yukimura Higashiura, et al.
Endocrine Journal (2021) Vol. 69, Iss. 4, pp. 463-471
Open Access | Times Cited: 34
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses
Kazuma Mori, Marenao Tanaka, Itaru Hosaka, et al.
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1110-1121
Closed Access | Times Cited: 16
Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period
Kazuma Mori, Marenao Tanaka, Tatsuya Sato, et al.
Hepatology Research (2024)
Open Access | Times Cited: 5
High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population
Yukimura Higashiura, Marenao Tanaka, Kazuma Mori, et al.
European Heart Journal Open (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 18
Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study
Marenao Tanaka, Yukinori Akiyama, Kazuma Mori, et al.
Clinical and Experimental Hypertension (2025) Vol. 47, Iss. 1
Open Access
Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals
Marenao Tanaka, Satoko Takahashi, Yukimura Higashiura, et al.
Journal of Diabetes Investigation (2021) Vol. 13, Iss. 5, pp. 878-888
Open Access | Times Cited: 23
High fatty liver index is an independent predictor of ischemic heart disease during a 10‐year period in a Japanese population
Kazuma Mori, Marenao Tanaka, Yukimura Higashiura, et al.
Hepatology Research (2022) Vol. 52, Iss. 8, pp. 687-698
Closed Access | Times Cited: 13
Predictive modeling for the development of diabetes mellitus using key factors in various machine learning approaches
Marenao Tanaka, Yukinori Akiyama, Kazuma Mori, et al.
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100191-100191
Open Access | Times Cited: 7
ZJU Index as a Predictive Tool for Diabetes Incidence: Insights from a Population-Based Cohort Study
Chenjiao Wu, Yi Hao Loh, Hangkai Huang, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 715-724
Open Access | Times Cited: 2
The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study
So Hee Park, Jiyun Park, Hasung Kim, et al.
Internal and Emergency Medicine (2024)
Closed Access | Times Cited: 2
Diagnostic ability using fatty liver and metabolic markers for metabolic‐associated fatty liver disease stratified by metabolic/glycemic abnormalities
Akira Okada, Gen Yamada, Takeshi Kimura, et al.
Journal of Diabetes Investigation (2022) Vol. 14, Iss. 3, pp. 463-478
Open Access | Times Cited: 11
Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
Iresha Sandamali Koralegedara, Janith Warnasekara, Ashani Rathnayake, et al.
BMJ Open Gastroenterology (2022) Vol. 9, Iss. 1, pp. e000913-e000913
Open Access | Times Cited: 10
Fatty liver index for hyperuricemia diagnosis: a community-based cohort study
Jianchang Qu, Jingtao Dou, Anping Wang, et al.
BMC Endocrine Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without Medication
Masato Furuhashi, Atsuko Muranaka, Satoshi Yuda, et al.
The American Journal of Cardiology (2021) Vol. 158, pp. 139-146
Closed Access | Times Cited: 12
Leveraging the future of diagnosis and management of diabetes: From old indexes to new technologies
Maria João Meneses, Rita S. Patarrão, Tomás Pinheiro, et al.
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 4
Open Access | Times Cited: 5
Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication
Masato Furuhashi, Yu Kataoka, Ryo Nishikawa, et al.
Journal of Atherosclerosis and Thrombosis (2021) Vol. 29, Iss. 9, pp. 1275-1284
Open Access | Times Cited: 4
Fatty Liver Index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The Suita Study
Ahmed Arafa, Rena Kashima, Chisa Matsumoto, et al.
Journal of Stroke and Cerebrovascular Diseases (2023) Vol. 33, Iss. 1, pp. 107495-107495
Closed Access | Times Cited: 1
Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Fatty Liver-Related Indices in a Japanese Population
Kengo Moriyama
Metabolic Syndrome and Related Disorders (2023) Vol. 22, Iss. 3, pp. 190-198
Closed Access | Times Cited: 1
The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: A nationwide cohort study
So Hee Park, Jiyun Park, Hasung Kim, et al.
Research Square (Research Square) (2024)
Open Access
Circulating Chemerin Levels in Obese and Non-obese Individuals and Its Association With Obesity in Metabolic Dysfunction-Associated Fatty Liver Disease
R Aravindraj, P Renuka, V. Vinodhini, et al.
Cureus (2024)
Open Access
Page 1 - Next Page

Scroll to top